Iterum Therapeutics plc (ITRMF) Invested Capital (2018 - 2024)
Iterum Therapeutics (ITRMF) posted quarterly Invested Capital of $14.5 million for Q4 2024, up 5.51% quarter-over-quarter from $13.7 million in Q3 2024.
Iterum Therapeutics plc (ITRMF) Invested Capital (2018 - 2024) Analysis & Trends
Iterum Therapeutics' Invested Capital history runs 5 years deep, the most recent figure standing at $14.5 million for Q4 2024.
- In Q4 2024, Invested Capital changed N/A year-over-year to $14.5 million; the TTM figure through Sep 2025 stood at $14.5 million (down 62.78% YoY), while the FY2024 annual figure was $14.5 million, changed N/A from the prior year.
- Invested Capital for Q4 2024 stood at $14.5 million, up from $13.7 million in the prior quarter.
- The five-year high for Invested Capital was $14.5 million in Q4 2024, with the low at $1.6 million in Q4 2021.
- The 3-year median for Invested Capital is $6.2 million (2020), against an average of $7.8 million.
- The sharpest annual moves came in 2020 and 2021: Invested Capital surged 185.36% in 2020, then tumbled 74.47% in 2021.
- Iterum Therapeutics' Invested Capital stood at $6.4 million in 2020, then sank by 74.47% to $1.6 million in 2021, then surged by 788.94% to $14.5 million in 2024.
- Business Quant data shows ITRMF's Invested Capital at $14.5 million in Q4 2024, $13.7 million in Q3 2024, and $13.0 million in Q2 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 14.46 Mn |
| Sep 30, 2024 | 13.71 Mn |
| Jun 30, 2024 | 12.95 Mn |
| Mar 31, 2024 | 12.20 Mn |
| Dec 31, 2021 | 1.63 Mn |
| Sep 30, 2021 | 3.24 Mn |
| Jun 30, 2021 | 4.85 Mn |
| Mar 31, 2021 | 6.43 Mn |
| Dec 31, 2020 | 6.37 Mn |
| Sep 30, 2020 | 6.08 Mn |
| Jun 30, 2020 | 5.93 Mn |
| Mar 31, 2020 | 5.87 Mn |
| Dec 31, 2019 | 5.80 Mn |
| Sep 30, 2019 | 5.00 Mn |
| Jun 30, 2019 | 3.50 Mn |
| Mar 31, 2019 | 2.06 Mn |
| Dec 31, 2018 | 1.02 Mn |